K.J.M. Moriarty

2.9k total citations
158 papers, 2.0k citations indexed

About

K.J.M. Moriarty is a scholar working on Nuclear and High Energy Physics, Condensed Matter Physics and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, K.J.M. Moriarty has authored 158 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Nuclear and High Energy Physics, 57 papers in Condensed Matter Physics and 23 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in K.J.M. Moriarty's work include Quantum Chromodynamics and Particle Interactions (72 papers), Particle physics theoretical and experimental studies (40 papers) and Theoretical and Computational Physics (40 papers). K.J.M. Moriarty is often cited by papers focused on Quantum Chromodynamics and Particle Interactions (72 papers), Particle physics theoretical and experimental studies (40 papers) and Theoretical and Computational Physics (40 papers). K.J.M. Moriarty collaborates with scholars based in United States, Canada and United Kingdom. K.J.M. Moriarty's co-authors include C. Rebbi, D. Barkai, Michael Creutz, William Roush, Bradley Brown, Massimo Campostrini, Eric Myers, Robin D. Rogers, Leo A. Paquette and Marvin D. Rausch and has published in prestigious journals such as Journal of the American Chemical Society, Physical Review Letters and Nuclear Physics B.

In The Last Decade

K.J.M. Moriarty

145 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.J.M. Moriarty United States 23 829 711 331 275 181 158 2.0k
Yong‐Qiang Wang China 25 538 0.6× 451 0.6× 132 0.4× 236 0.9× 215 1.2× 127 1.8k
H. Kluge Germany 28 1.7k 2.0× 241 0.3× 173 0.5× 157 0.6× 723 4.0× 115 2.4k
Richard E. Taylor United States 35 1.7k 2.0× 1.5k 2.1× 72 0.2× 620 2.3× 367 2.0× 131 4.1k
F. Nicolò Italy 25 259 0.3× 1.2k 1.6× 62 0.2× 234 0.9× 107 0.6× 192 2.5k
Yu. A. Simonov Russia 33 3.9k 4.7× 228 0.3× 225 0.7× 77 0.3× 459 2.5× 354 4.8k
Kamal K. Seth United States 26 1.8k 2.1× 125 0.2× 174 0.5× 322 1.2× 626 3.5× 117 2.4k
D. Müller Germany 25 1.0k 1.2× 531 0.7× 80 0.2× 486 1.8× 85 0.5× 125 2.1k
D. L. Weaver United States 26 405 0.5× 339 0.5× 56 0.2× 1.5k 5.5× 433 2.4× 103 3.0k
Neil S. Ostlund United States 20 116 0.1× 624 0.9× 132 0.4× 238 0.9× 2.4k 13.3× 35 3.8k
David J.E. Callaway United States 27 585 0.7× 96 0.1× 203 0.6× 1.1k 4.0× 415 2.3× 72 2.7k

Countries citing papers authored by K.J.M. Moriarty

Since Specialization
Citations

This map shows the geographic impact of K.J.M. Moriarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.J.M. Moriarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.J.M. Moriarty more than expected).

Fields of papers citing papers by K.J.M. Moriarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.J.M. Moriarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.J.M. Moriarty. The network helps show where K.J.M. Moriarty may publish in the future.

Co-authorship network of co-authors of K.J.M. Moriarty

This figure shows the co-authorship network connecting the top 25 collaborators of K.J.M. Moriarty. A scholar is included among the top collaborators of K.J.M. Moriarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.J.M. Moriarty. K.J.M. Moriarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kröger, H., et al.. (2008). Quantum Instantons and Quantum Chaos. 3 indexed citations
2.
Caron, Laurent, et al.. (2008). Quantum Chaos at Finite Temperature. 5 indexed citations
3.
Winters, Michael P., Steven S. Pullen, Joseph R. Woska, et al.. (2008). 5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk). Bioorganic & Medicinal Chemistry Letters. 18(20). 5541–5544. 18 indexed citations
4.
Moriarty, K.J.M., Michael P. Winters, Lei Qiao, et al.. (2008). Itk kinase inhibitors: Initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead. Bioorganic & Medicinal Chemistry Letters. 18(20). 5537–5540. 23 indexed citations
5.
Kervinen, Jukka, Hongchang Ma, Shariff Bayoumy, et al.. (2006). Effect of construct design on MAPKAP kinase-2 activity, thermodynamic stability and ligand-binding affinity. Archives of Biochemistry and Biophysics. 449(1-2). 47–56. 15 indexed citations
6.
Moriarty, K.J.M., Holly K. Koblish, Thomas Garrabrant, et al.. (2006). The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: A new class of Aurora-A kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(22). 5778–5783. 54 indexed citations
7.
Moriarty, K.J.M., et al.. (2005). Alternative perspective on quantum tunneling and instantons (9 pages). Physical Review A. 71(2). 22106. 1 indexed citations
8.
Chiba, Jun, Gensuke Takayama, Tohru Takashi, et al.. (2005). Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists. Bioorganic & Medicinal Chemistry. 14(8). 2725–2746. 31 indexed citations
9.
Kröger, H., et al.. (2004). New Vista on Quantum Tunneling and Instantons. arXiv (Cornell University). 1 indexed citations
11.
Regan, John R., Frank Volz, Christopher Hulme, et al.. (1999). Benzofuran based PDE4 inhibitors. Bioorganic & Medicinal Chemistry. 7(6). 1131–1139. 11 indexed citations
12.
Huang, Fu‐Chih, K.J.M. Moriarty, De-Cheng Zhang, et al.. (1998). Novel cytokine release inhibitors. Part I: Triterpenes. Bioorganic & Medicinal Chemistry Letters. 8(14). 1883–1886. 35 indexed citations
13.
Hulme, Christopher, K.J.M. Moriarty, Bruce E. Miller, et al.. (1998). The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I. Bioorganic & Medicinal Chemistry Letters. 8(14). 1867–1872. 15 indexed citations
14.
Hulme, Christopher, Rose Mathew, K.J.M. Moriarty, et al.. (1998). Orally active indole N-oxide PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(21). 3053–3058. 9 indexed citations
15.
Hulme, Christopher, K.J.M. Moriarty, Fu‐Chih Huang, et al.. (1998). Quaternary substituted PDE IV inhibitors II: The synthesis and in vitro evaluation of a novel series of γ-lactams. Bioorganic & Medicinal Chemistry Letters. 8(4). 399–404. 9 indexed citations
17.
Samuel, Stuart & K.J.M. Moriarty. (1987). Static properties of hadrons from scalar lattice QCD. Nuclear Physics B. 281(3-4). 670–725. 4 indexed citations
18.
Samuel, Stuart, Olivier Martin, & K.J.M. Moriarty. (1985). Seeing asymptotic freedom in SU(3) lattice gauge theory. Physics Letters B. 153(1-2). 87–91. 19 indexed citations
19.
Moriarty, K.J.M.. (1981). Phase diagram of SO(2) lattice gauge theory in four dimensions. Journal of Physics G Nuclear Physics. 7(2). L19–L24. 2 indexed citations
20.
Moriarty, K.J.M.. (1981). The high-temperature expansion and Monte-Carlo simulation of compact U(1) gauge theory on a four-dimensional lattice: a comparison. Journal of Physics G Nuclear Physics. 7(8). L161–L163. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026